Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis-Reference-Cited by-同舟云学术

Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis

Published:2022-11 Issue:11 Volume:142 Page:3009-3019.e9
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Picozza Mario^ORCID,Cristofoletti Cristina^ORCID,Bresin Antonella^ORCID,Fioretti Martina^ORCID,Sambucci Manolo^ORCID,Scala Enrico^ORCID,Monopoli Alessandro^ORCID,Cantonetti Maria^ORCID,Pilla Maria Antonietta^ORCID,Accetturi Maria Pina^ORCID,Borsellino Giovanna^ORCID,D’Atri Stefania^ORCID,Caprini Elisabetta^ORCID,Russo Giandomenico^ORCID,Narducci Maria Grazia^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference58 articles.

1. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial;Bagot;Lancet Oncol,2019

2. Dimensionality reduction for visualizing single-cell data using UMAP.;Becht;Nat Biotechnol,2019

3. Identification of CD39 as a marker for the circulating malignant T-cell clone of Sézary syndrome patients;Bensussan;J Invest Dermatol,2019

4. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression;Borsellino;Blood,2007

5. High expression of CD39 in gastric cancer reduces patient outcome following radical resection;Cai;Oncol Lett,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD39 transforming cancer therapy by modulating tumor microenvironment;Cancer Letters;2024-08

2. CD39 is expressed by a wide range of cutaneous T‐cell lymphomas;Skin Health and Disease;2024-01-10

3. Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment;Frontiers in Oncology;2023-09-07

4. CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sézary syndrome;Blood;2023-01-05

5. Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome;Cancers;2022-06-09